Top Biotechnology companies in Americas by Free Cash Flow

This ranking features the top 540 Biotechnology companies in Americas ranked by Free Cash Flow, totaling a Free Cash Flow of USD 89.94 B, for July 04, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

…

Frequently Asked Questions

Which Biotechnology company in Americas has the highest Free Cash Flow ?

The Biotechnology company in Americas with the highest Free Cash Flow is Merck & Co., Inc. (NYSE: MRK) at USD 17.04 B.

Which Biotechnology company in Americas has the lowest Free Cash Flow ?

The Biotechnology company in Americas with the lowest Free Cash Flow is Autonomix Medical, Inc. Common Stock (NasdaqCM: AMIX) at None.

What are the top 10 Biotechnology companies in Americas by Free Cash Flow ?

The top 10 Biotechnology companies in Americas by Free Cash Flow are Merck & Co., Inc., AbbVie Inc., Bristol-Myers Squibb Company, Pfizer Inc., Amgen Inc., Gilead Sciences, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation and Regeneron Pharmaceuticals, Inc..

What are the bottom 10 Biotechnology companies in Americas by Free Cash Flow ?

The bottom 10 Biotechnology companies in Americas by Free Cash Flow are Autonomix Medical, Inc. Common Stock, Aldeyra Therapeutics, Inc., Agrify Corporation, Alzamend Neuro, Inc., AgriFORCE Growing Systems Ltd., Adverum Biotechnologies, Inc., ABVC BioPharma, Inc., Actuate Therapeutics Inc, Aditxt, Inc. and Anebulo Pharmaceuticals, Inc..